Blog
RSS FeedPosted by Michael Wonder on 28 Oct 2020
Leo Pharma is withdrawing the drug Picato (ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
27 October 2020 - At Health Canada's request, Leo Pharma is withdrawing Picato from the Canadian market. ...
Posted by Michael Wonder on 01 Oct 2020
Fibristal (ulipristal acetate 5 mg tablets) voluntary withdrawal in Canada due to risk of drug-induced liver injury
30 September 2020 - Allergan is working closely with Health Canada to voluntarily withdraw Fibristal (ulipristal acetate 5 mg tablets) ...
Posted by Michael Wonder on 27 Apr 2020
Health Canada issues warning against use of hydroxychloroquine for COVID-19
26 April 2020 - Health Canada is warning the public of the possible side effects of a drug that U.S. ...
Posted by Michael Wonder on 23 May 2019
B.C. eye doctors warn province of spike in glaucoma cases linked to injections of eye drug
23 May 2019 - Thousands of retinal-disease patients in British Columbia are being exposed to an “increased risk of severe ...
Posted by Michael Wonder on 15 Jan 2019
Health Canada restricts Allergan's Esmya
15 January 2019 - Health Canada has placed restrictions on Allergan's uterine fibroid treatment Esmya, after discovering a possible link ...
Posted by Michael Wonder on 12 Nov 2018
Oversight gap at private infusion clinics poses health risk, Ontario documents say
12 November 2018 - The lack of formal oversight at private clinics where medications are administered intravenously could pose risks ...